Document Detail


Effect of L-arginine oral supplementation on response to myocardial infarction in hypercholesterolemic and hypertensive rats.
MedLine Citation:
PMID:  20087664     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The well known metabolic functions of L-arginine have been recently increased with the discovery of its role as the substrate for the synthesis of nitric oxide (NO), which has emerged as an endogenous signaling molecule with potential therapeutic implications for cardiovascular disease. Steady-state levels of NO are derived in part from dietary sources. It has been reported that supplementation of L-arginine reduces atherosclerosis in rabbits and reduces the arterial pressure in hypertensive rats. Therefore, we investigated the effect of L-arginine supplementation using a group of induced hypercholesterolemic rats and a group of spontaneously hypertensive rats; the infarcted area in cardiac tissue of both groups was measured during the response to myocardial infarction in the ischemia-reperfusion model. Hypercholesterolemic rats supplemented with 170 mg kg(-1) of L-arginine showed a significant (P <or= 0.05) reduction in total cholesterol (25.2%) and LDL (27.8%). Spontaneously hypertensive rats supplemented with L-arginine presented a significant reduction (20.3%) in mean blood pressure (P <or= 0.05). The index infarcted area/total heart area, in both: hypercholesterolemic and hypertensive rats supplemented with L-arginine, showed a significant 36% and 29% of cardio protection (P <or= 0.05) effect, respectively. Dietary supplementation with L-arginine may represent a potentially novel nutritional strategy for the treatment of cardiovascular disease.
Authors:
Verónica Piñeiro; Alicia Ortiz-Moreno; Rosalva Mora-Escobedo; María Dolores Hernández-Navarro; Guillermo Ceballos-Reyes; Germán Chamorro-Cevallos
Related Documents :
2796714 - Lack of portal-venous hypertension after an arterioportal fistula in the rat.
1248654 - Urinary kallikrein in hypertensive animal models.
16940214 - Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of...
1669834 - Characterisation of neutral endopeptidase 3.4.24.11 (nep) in the kidney: comparison bet...
9145214 - Hepatoprotective effect of hovenia dulcis thunb. on experimental liver injuries induced...
631434 - The development of sexual behavior in the rat: role of preadult nutrition and environme...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Plant foods for human nutrition (Dordrecht, Netherlands)     Volume:  65     ISSN:  1573-9104     ISO Abbreviation:  Plant Foods Hum Nutr     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-18     Completed Date:  2010-08-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8803554     Medline TA:  Plant Foods Hum Nutr     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  31-7     Citation Subset:  IM    
Affiliation:
Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, México, DF, México.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Animals
Arginine / pharmacology,  therapeutic use*
Blood Pressure / drug effects*
Cardiovascular Agents / pharmacology,  therapeutic use*
Dietary Supplements*
Hypercholesterolemia / drug therapy*
Hypertension / drug therapy*
Male
Myocardial Infarction / drug therapy*
Myocardium / pathology
Nitric Oxide
Random Allocation
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Chemical
Reg. No./Substance:
0/Cardiovascular Agents; 10102-43-9/Nitric Oxide; 74-79-3/Arginine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Social-adaptive and psychological functioning of patients affected by Fabry disease.
Next Document:  High risk for neoplastic transformation of endometriosis in a carrier of Lynch syndrome.